Trgovina Cyclo Therapeutics, Inc. - CYTH CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.41 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 0.67-2.75 |
Povprečni obseg (10 dni) | 50.68K |
Povprečni obseg (3 meseci) | 2.97M |
Tržna kapitalizacija | 19.54M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 15.17M |
Prihodki | 1.38M |
EPS | -1.83 |
Dividenda (donosnost v %) | N/A |
Beta | -0.42 |
Datum naslednjega zaslužka | Aug 14, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 27, 2022 | 1.93 | -0.01 | -0.52% | 1.94 | 1.94 | 1.93 |
May 23, 2022 | 1.91 | 0.00 | 0.00% | 1.91 | 1.91 | 1.91 |
Mar 28, 2022 | 2.39 | -0.01 | -0.42% | 2.40 | 2.40 | 2.39 |
Feb 24, 2022 | 2.78 | 0.00 | 0.00% | 2.78 | 2.78 | 2.78 |
Feb 11, 2022 | 3.36 | -0.38 | -10.16% | 3.74 | 3.74 | 3.28 |
Feb 10, 2022 | 3.69 | 0.15 | 4.24% | 3.54 | 3.93 | 3.54 |
Feb 9, 2022 | 3.72 | 0.20 | 5.68% | 3.52 | 3.81 | 3.52 |
Feb 8, 2022 | 3.62 | 0.19 | 5.54% | 3.43 | 3.64 | 3.43 |
Feb 7, 2022 | 3.57 | 0.00 | 0.00% | 3.57 | 3.59 | 3.23 |
Feb 4, 2022 | 3.49 | 0.06 | 1.75% | 3.43 | 3.64 | 3.09 |
Feb 3, 2022 | 3.44 | -0.19 | -5.23% | 3.63 | 3.73 | 3.31 |
Feb 2, 2022 | 3.56 | -0.19 | -5.07% | 3.75 | 3.77 | 3.48 |
Feb 1, 2022 | 3.79 | -0.03 | -0.79% | 3.82 | 3.84 | 3.52 |
Jan 31, 2022 | 3.66 | 0.05 | 1.39% | 3.61 | 3.71 | 3.51 |
Jan 28, 2022 | 3.57 | 0.04 | 1.13% | 3.53 | 3.63 | 3.46 |
Jan 27, 2022 | 3.52 | -0.14 | -3.83% | 3.66 | 3.71 | 3.46 |
Jan 26, 2022 | 3.74 | 0.01 | 0.27% | 3.73 | 3.95 | 3.66 |
Jan 25, 2022 | 3.77 | 0.19 | 5.31% | 3.58 | 3.95 | 3.58 |
Jan 24, 2022 | 3.57 | -0.10 | -2.72% | 3.67 | 3.79 | 3.38 |
Jan 21, 2022 | 3.76 | -0.14 | -3.59% | 3.90 | 3.90 | 3.68 |
Cyclo Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Monday, August 14, 2023 | ||
Čas (UTC) (UTC) 20:00 | Država US
| Dogodek Q2 2023 Cyclo Therapeutics Inc Earnings Release Q2 2023 Cyclo Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 1.37576 | 1.58576 | 0.90338 | 1.0072 | 1.01148 |
Prihodki | 1.37576 | 1.58576 | 0.90338 | 1.0072 | 1.01148 |
Celotni stroški prihodkov | 0.14995 | 0.16679 | 0.07359 | 0.08379 | 0.10885 |
Bruto dobiček | 1.22581 | 1.41897 | 0.82979 | 0.92341 | 0.90263 |
Celotni odhodki iz poslovanja | 16.8391 | 15.8758 | 9.86478 | 8.55176 | 5.27828 |
Celotna prodaja/splošni/upravni stroški Odhodki | 7.82867 | 6.53842 | 3.68199 | 3.43936 | 2.43589 |
Raziskave in razvoj | 8.99954 | 9.15378 | 6.09645 | 4.86916 | 2.71128 |
Depreciation / Amortization | 0.01948 | 0.01683 | 0.01276 | 0.00568 | 0.01012 |
Nenavadni odhodki (prihodki) | -0.15852 | 0 | 0.15377 | 0.01215 | |
Prihodki iz poslovanja | -15.4634 | -14.2901 | -8.9614 | -7.54456 | -4.2668 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.01247 | 0.00341 | 0.0198 | 0.01203 | 0.01177 |
Čisti dobiček pred obdavčitvijo | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Čisti dobiček po davkih | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Čisti dobiček pred dodatnimi postavkami | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Čisti dobiček | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Popravljen čisti dobiček | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Popravljene ponderirane povprečne delnice | 8.43918 | 6.37007 | 1.59922 | 1.08192 | 0.81757 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.83085 | -2.24278 | -5.59122 | -6.96221 | -5.2045 |
Popravljen normalizirani dobiček na enoto čistega dobička | -1.84964 | -2.24278 | -5.59122 | -6.82008 | -5.18964 |
Skupaj izredne postavke | 0 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0.1868 | 0.45217 | 0.54189 | 0.1949 | 0.58512 |
Prihodki | 0.1868 | 0.45217 | 0.54189 | 0.1949 | 0.58512 |
Celotni stroški prihodkov | 0.01661 | 0.03521 | 0.07734 | 0.02079 | 0.07363 |
Bruto dobiček | 0.17019 | 0.41696 | 0.46455 | 0.17411 | 0.51149 |
Celotni odhodki iz poslovanja | 5.16971 | 4.70067 | 3.99791 | 2.97084 | 3.37843 |
Celotna prodaja/splošni/upravni stroški Odhodki | 1.96328 | 1.80417 | 2.04144 | 2.01978 | 1.8862 |
Raziskave in razvoj | 3.18495 | 2.85616 | 1.87438 | 1.08405 | 1.4144 |
Depreciation / Amortization | 0.00487 | 0.00513 | 0.00474 | 0.00474 | 0.00421 |
Prihodki iz poslovanja | -4.98291 | -4.2485 | -3.45602 | -2.77594 | -2.79331 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.00248 | 0.00162 | 0.00403 | 0.00434 | 0.00093 |
Čisti dobiček pred obdavčitvijo | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Čisti dobiček po davkih | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Čisti dobiček pred dodatnimi postavkami | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Čisti dobiček | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Popravljen čisti dobiček | -4.98043 | -4.24688 | -3.45199 | -2.77159 | -2.79239 |
Popravljene ponderirane povprečne delnice | 8.47249 | 8.44763 | 8.4179 | 8.4118 | 7.35872 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.58784 | -0.50273 | -0.41008 | -0.32949 | -0.37947 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.58784 | -0.50273 | -0.41008 | -0.34833 | -0.37947 |
Nenavadni odhodki (prihodki) | 0 | 0 | 0 | -0.15852 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 4.15856 | 19.4363 | 14.0502 | 3.95807 | 2.76961 |
Denarna sredstva in kratkoročne naložbe | 1.54342 | 16.6127 | 12.8461 | 2.78372 | 2.21741 |
Denarna sredstva in ustrezniki | 1.54342 | 16.6127 | 12.8461 | 2.78372 | 2.21741 |
Celotne terjatve, neto | 0.05499 | 0.53909 | 0.11179 | 0.18249 | 0.11748 |
Accounts Receivable - Trade, Net | 0.05499 | 0.49311 | 0.07102 | 0.14343 | 0.08004 |
Total Inventory | 0.25449 | 0.22744 | 0.23791 | 0.24263 | 0.41653 |
Prepaid Expenses | 2.30566 | 2.0571 | 0.85443 | 0.74923 | 0.01819 |
Total Assets | 4.21521 | 19.5208 | 14.188 | 4.11323 | 2.91786 |
Property/Plant/Equipment, Total - Net | 0.05666 | 0.07722 | 0.08792 | 0.06456 | 0.01857 |
Note Receivable - Long Term | 0 | 0.00728 | 0.04981 | 0.0906 | 0.12967 |
Other Long Term Assets, Total | |||||
Total Current Liabilities | 3.48067 | 3.83094 | 3.67255 | 3.14112 | 1.92533 |
Payable/Accrued | 3.48067 | 3.67798 | 3.54104 | 3.12474 | 1.92533 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.13371 | 0.11403 | ||
Total Liabilities | 3.48067 | 3.84897 | 3.73548 | 3.17725 | 1.92533 |
Total Long Term Debt | 0 | 0.01803 | 0.0445 | 0 | 0 |
Total Equity | 0.73454 | 15.6719 | 10.4525 | 0.93598 | 0.99252 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.00085 | 0.00084 | 0.00048 | 0.01216 | 0.00908 |
Additional Paid-In Capital | 64.5331 | 64.0195 | 44.5138 | 26.0441 | 18.7012 |
Retained Earnings (Accumulated Deficit) | -63.7994 | -48.3485 | -34.0618 | -25.1202 | -17.5877 |
Total Liabilities & Shareholders’ Equity | 4.21521 | 19.5208 | 14.188 | 4.11323 | 2.91786 |
Total Common Shares Outstanding | 8.48185 | 8.40387 | 4.77076 | 1.21565 | 0.90759 |
Total Preferred Shares Outstanding | 0 | 0 | |||
Other Equity, Total | -0.13006 | ||||
Property/Plant/Equipment, Total - Gross | 0.1582 | 0.15928 | 0.15315 | 0.11703 | |
Accumulated Depreciation, Total | -0.10154 | -0.08206 | -0.06523 | -0.05247 | |
Accrued Expenses | 0 | 0.01925 | 0.01748 | 0.01639 | |
Other Liabilities, Total | 0 | 0.01843 | 0.03613 | ||
Long Term Debt | 0 | 0.01803 | 0.0445 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 4.15856 | 8.4218 | 11.777 | 15.8502 | 19.4363 |
Denarna sredstva in kratkoročne naložbe | 1.54342 | 4.2902 | 7.45339 | 11.7986 | 16.6127 |
Denarna sredstva in ustrezniki | 1.54342 | 4.2902 | 7.45339 | 11.7986 | 16.6127 |
Celotne terjatve, neto | 0.05499 | 0.39457 | 0.43869 | 0.15772 | 0.53909 |
Accounts Receivable - Trade, Net | 0.05499 | 0.39457 | 0.40993 | 0.11838 | 0.49311 |
Total Inventory | 0.25449 | 0.27114 | 0.26061 | 0.22106 | 0.22744 |
Prepaid Expenses | 2.30566 | 3.46589 | 3.62434 | 3.6729 | 2.0571 |
Total Assets | 4.21521 | 8.48752 | 11.8418 | 15.9242 | 19.5208 |
Property/Plant/Equipment, Total - Net | 0.05666 | 0.06573 | 0.06478 | 0.07393 | 0.07722 |
Note Receivable - Long Term | 0 | 0 | 0 | 0 | 0.00728 |
Total Current Liabilities | 3.48067 | 2.87506 | 2.10177 | 2.87614 | 3.83094 |
Payable/Accrued | 3.48067 | 2.87009 | 2.09197 | 2.86158 | 3.67798 |
Accrued Expenses | 0 | 0.00498 | 0.00981 | 0.01456 | 0.01925 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | 0.13371 |
Total Liabilities | 3.48067 | 2.87506 | 2.10177 | 2.87614 | 3.84897 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0.01803 |
Long Term Debt | 0 | 0 | 0 | 0 | 0.01803 |
Other Liabilities, Total | 0 | ||||
Total Equity | 0.73454 | 5.61246 | 9.74004 | 13.048 | 15.6719 |
Common Stock | 0.00085 | 0.00085 | 0.00084 | 0.00084 | 0.00084 |
Additional Paid-In Capital | 64.5331 | 64.4306 | 64.3113 | 64.1673 | 64.0195 |
Retained Earnings (Accumulated Deficit) | -63.7994 | -58.819 | -54.5721 | -51.1201 | -48.3485 |
Total Liabilities & Shareholders’ Equity | 4.21521 | 8.48752 | 11.8418 | 15.9242 | 19.5208 |
Total Common Shares Outstanding | 8.48185 | 8.45545 | 8.43944 | 8.4152 | 8.40387 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -15.4509 | -14.2867 | -8.9416 | -7.53253 | -4.25503 |
Denarna sredstva iz poslovanja | -15.1142 | -15.0053 | -8.54019 | -6.58949 | -3.18844 |
Denarna sredstva iz poslovanja | 0.01948 | 0.01683 | 0.01276 | 0.00568 | 0.01012 |
Deferred Taxes | |||||
Nedenarne postavke | 0.36532 | 0.4928 | 0.27131 | 0.44996 | 0.09557 |
Cash Taxes Paid | 0 | 0 | |||
Denarna sredstva Plačane obresti | 0 | 0.00353 | 0.00053 | 0 | 0 |
Spremembe v obratnem kapitalu | -0.04815 | -1.22827 | 0.11735 | 0.4874 | 0.9609 |
Denarna sredstva pri naložbenju | 0.03817 | 0.01482 | -0.01405 | 0.03613 | 0.03294 |
Kapitalski izdatki | -0.01509 | -0.0225 | -0.05313 | -0.00132 | -0.00296 |
Celotne druge postavke denarnih tokov pri naložbenju | 0.05326 | 0.03732 | 0.03908 | 0.03746 | 0.0359 |
Denarna sredstva pri financiranju | 0.00678 | 18.7571 | 18.6166 | 7.11966 | 4.10194 |
Izdaja (odplačilo) delnic, neto | 18.7638 | 18.4581 | 6.9896 | 4.10194 | |
Izdaja (odplačilo) dolga, neto | 0.00678 | -0.00678 | 0.15852 | ||
Neto sprememba denarnih sredstev | -15.0693 | 3.7666 | 10.0624 | 0.56631 | 0.94644 |
Postavke denarnega toka pri financiranju | 0 | 0.13006 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.4509 | -10.4705 | -6.22358 | -2.77159 | -14.2867 |
Cash From Operating Activities | -15.1142 | -12.3675 | -9.18599 | -4.83025 | -15.0053 |
Cash From Operating Activities | 0.01948 | 0.01461 | 0.00948 | 0.00474 | 0.01683 |
Non-Cash Items | 0.36532 | 0.23078 | 0.13324 | -0.01078 | 0.4928 |
Cash Taxes Paid | |||||
Cash Interest Paid | 0 | 0 | 0 | 0 | 0.00353 |
Changes in Working Capital | -0.04815 | -2.14239 | -3.10513 | -2.05262 | -1.22827 |
Cash From Investing Activities | 0.03817 | 0.03817 | 0.01989 | 0.00932 | 0.01482 |
Capital Expenditures | -0.01509 | -0.01509 | -0.0046 | -0.0046 | -0.0225 |
Other Investing Cash Flow Items, Total | 0.05326 | 0.05326 | 0.02449 | 0.01392 | 0.03732 |
Cash From Financing Activities | 0.00678 | 0.00678 | 0.00678 | 0.00678 | 18.7571 |
Issuance (Retirement) of Stock, Net | 0 | 18.7638 | |||
Net Change in Cash | -15.0693 | -12.3225 | -9.15932 | -4.81416 | 3.7666 |
Issuance (Retirement) of Debt, Net | 0.00678 | 0.00678 | 0.00678 | 0.00678 | -0.00678 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Rafael Holdings Inc | Corporation | 16.5803 | 2514970 | 2514970 | 2023-05-02 | |
Lisjak (Michael Eric) | Individual Investor | 8.6047 | 1305189 | 1292789 | 2023-04-28 | |
Novit, L.P. | Corporation | 6.2641 | 950156 | 950156 | 2023-04-28 | |
Armistice Capital LLC | Hedge Fund | 3.9754 | 603000 | -427000 | 2023-03-31 | HIGH |
Fine (Nathan Scott) | Individual Investor | 2.9298 | 444402 | 299402 | 2023-04-28 | LOW |
Strattan (C E Rick) | Individual Investor | 2.2864 | 346805 | 21360 | 2023-05-17 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.6738 | 253882 | 0 | 2023-03-31 | LOW |
Ostronic Francis Patrick | Individual Investor | 1.642 | 249071 | 26700 | 2023-05-17 | LOW |
Sieger (Markus) | Individual Investor | 1.345 | 204013 | 42962 | 2023-05-17 | LOW |
Shanahan (William S) | Individual Investor | 0.591 | 89648 | 25971 | 2023-05-17 | |
Toig Randall M | Individual Investor | 0.526 | 79781 | 23059 | 2023-05-17 | |
Tate (Jeffrey L) | Individual Investor | 0.4094 | 62101 | 29941 | 2023-04-28 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3445 | 52253 | 0 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1866 | 28300 | 0 | 2023-03-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.122 | 18501 | 18501 | 2023-03-31 | HIGH |
Kjems (Lise Lund) | Individual Investor | 0.1124 | 17053 | 0 | 2023-01-25 | |
Tower Research Capital LLC | Hedge Fund | 0.0788 | 11953 | 7168 | 2023-03-31 | HIGH |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.0656 | 9953 | 0 | 2023-01-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.0148 | 2249 | 0 | 2023-03-31 | LOW |
Clear Street Markets LLC | Research Firm | 0.0114 | 1725 | 1725 | 2023-03-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cyclo Therapeutics, Inc. Company profile
O družbi Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc. je biotehnološko podjetje v klinični fazi, ki razvija izdelke na osnovi ciklodekstrina za zdravljenje bolezni. Glavni kandidat za zdravilo Trappsol Cyclo (hidroksipropil beta ciklodekstrin) je namenjen zdravljenju bolezni Niemann-Pick tipa C (NPC). NPC je redka in usodna bolezen presnove holesterola, ki prizadene možgane, pljuča, jetra, vranico in druge organe. Osredotoča se tudi na uporabo ciklodekstrinov pri zdravljenju Alzheimerjeve bolezni. Liniji izdelkov družbe vključujeta Trappsol in Aquaplex. Svoje kemične izdelke prodaja neposredno strankam v farmacevtski, diagnostični in industrijski kemični industriji ter distributerjem kemičnih izdelkov. Družba prodaja tudi ciklodekstrine in sorodne izdelke farmacevtski, prehranski in drugi industriji, predvsem za uporabo v diagnostiki in specialnih zdravilih.
Industry: | Pharmaceuticals (NEC) |
6714 Nw 16Th Street,
Suite B
GAINESVILLE
FLORIDA 32653
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com